Novinky

Pharmnet submitted for approval 25th pediatric trial

Pharmnet submitted for approval 25th pediatric trial

(9. 5. 2017)

Pharmnet continues successfuly in delivering the reliable results within the expected timelines while stays successfully adherent to the timelines passing all challenges specific for pediatric trials.

Více informací
EU Regulation no. 536/2014 implemented in Czech local regulations

EU Regulation no. 536/2014 implemented in Czech local regulations

(3. 4. 2017)

The new EU Regulation no. 536/2014 was implemented in Czech Republic regulations. Particularly, the “Drug law” no. 378/2007 Coll. was amended by law no. 66/2017 Coll. This new local regulation entered into force in March 2017...

Více informací
Renewed french CIR certificate

Renewed french CIR certificate

(11. 5. 2015)

Pharmnet has succesfully extended its french CIR status offering to our french partners to benefit from tax credit for R&D activities.

Více informací
New Informed Consent regulation in Czech Republic

New Informed Consent regulation in Czech Republic

(8. 1. 2015)

Czech national regulatory authority issued new regulation providing detailed guidance on patient information and informed consents for clinical trials in Czech Republic.

Více informací
Collaboration with The National Cell and Tissue Centre

Collaboration with The National Cell and Tissue Centre

(18. 9. 2014)

Pharmnet s.r.o. and Národní Centrum Tkání a Buněk a.s. (The National Cell and Tissue Centre, NCTB), member of PrimeCell Therapeutics group, are proud to announce joint collaboration on the clinical trial sponsored by Innovacell...

Více informací
Across Alliance
@PharmnetCZ nemá žádné tweety.
LinkedIn
Pharmnet © 2019